Neurokinin-1 receptor antagonism, aprepitant, effectively diminishes post-operative nausea and vomiting while increasing analgesic tolerance in laparoscopic gynecological procedures
スポンサーリンク
概要
- 論文の詳細を見る
Purpose : Post-operative nausea and vomiting (PONV) remains the most frequentlyreported patient complaint after anesthesia. Aprepitant is the first neurokinin-1(NK1) receptor antagonism available for use as an antiemetic. We investigated whetheraprepitant can effectively decrease PONV in patients undergoing laparoscopic gynecologicalsurgery. Methods : Sixty four patients receiving general anesthesia for laparoscopicgynecological surgery were randomly assigned to either receive a preoperative dose of 80mg aprepitant or no drug. Efficacy was assessed in 2 and 24 hours after surgery. Primaryand secondary endpoints were analyzed for the time intervals 0-2 hours (acute phase)and 2-24 hours (delayed phase). Vomiting, nausea, use of rescue anti-emetic, and visualanalog scale (VAS) were assessed. Nausea was assessed on a 4-point scale, from 0 to 3.Results : Sixty patients participated in the study. At acute phase, PONV was present inboth control and NK1 group and were 63% and 43% respectively. The severity of nauseawas much less in the NK1 group. PONV prevalence at delayed phase was present in controlbut absent in NK1 group 27% vs. 0%, respectively. The amount of pain medication usedby patients in the NK1 group was significantly less for diclofenac and pentazocine suggestingincrease pain tolerance. Conclusions : Neurokinin-1 receptor antagonism effectivelylowered PONV increased pain tolerance, and expedited recovery in patients undergoinglaparoscopic gynecological surgery.
論文 | ランダム
- プロダクションシステムで記述された通信ソフトウェア仕様の検証方式の一検討
- 有利な種類と新経営
- 状態遷移指向の仕様検証における状態検索の効率化方式
- 農業経営と畜産-これからの畜産経営-
- マルチエージェント協調プロトコルのコンカレントモデル